Cost analysis for initiating an integrated package of essential non-communicable disease interventions (PEN-Plus) in Kondoa District Hospital, Tanzania: a time-driven activity-based costing (TDABC) study protocol

• Published in: BMJ open Vol. 14; no. 5; p. e080510
• Main Authors: Ndumwa, Harrieth Peter, Mori, Amani Thomas, Ruhago, George Mugambage, Willilo, Ritha, McBain, Ryan, Boudreaux, Chantelle, Wroe, Emily, Adler, Alma J, Bukhman, Gene, Mayige, Mary Theodory, Kaarboe, Oddvar
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 01-05-2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Activity based costing; Anemia, Sickle Cell - economics; Anemia, Sickle Cell - therapy; Capital costs; Cardiovascular Disease; Cost estimates; Costs and Cost Analysis; Data collection; Diabetes; DIABETES & ENDOCRINOLOGY; Health care expenditures; Health economics; Health facilities; Hospitals; Hospitals, District - economics; Humans; Indigent care; Infectious diseases; Job titles; Noncommunicable Diseases - economics; Noncommunicable Diseases - therapy; Patients; Pharmacy; Primary Healthcare; PUBLIC HEALTH; Research Design; Sickle cell disease; Tanzania; Value chain; Tanzania; United States > US; Rwanda; Cardiovascular Disease; PUBLIC HEALTH; DIABETES & ENDOCRINOLOGY; Primary Healthcare; HEALTH ECONOMICS
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-080510

IntroductionNon-communicable diseases (NCDs) constitute approximately 74% of global mortality, with 77% of these deaths occurring in low-income and middle-income countries. Tanzania exemplifies this situation, as the percentage of total disability-adjusted life years attributed to NCDs has doubled over the past 30 years, from 18% to 36%. To mitigate the escalating burden of severe NCDs, the Tanzanian government, in collaboration with local and international partners, seeks to extend the integrated package of essential interventions for severe NCDs (PEN-Plus) to district-level facilities, thereby improving accessibility. This study aims to estimate the cost of initiating PEN-Plus for rheumatic heart disease, sickle cell disease and type 1 diabetes at Kondoa district hospital in Tanzania.Methods and analysisWe will employ time-driven activity-based costing (TDABC) to quantify the capacity cost rates (CCR), and capital and recurrent costs associated with the implementation of PEN-Plus. Data on resource consumption will be collected through direct observations and interviews with nurses, the medical officer in charge and the heads of laboratory and pharmacy units/departments. Data on contact times for targeted NCDs will be collected by observing a sample of patients as they move through the care delivery pathway. Data cleaning and analysis will be done using Microsoft Excel.Ethics and disseminationEthical approval to conduct the study has been waived by the Norwegian Regional Ethics Committee and was granted by the Tanzanian National Health Research Ethics Committee NIMR/HQ/R.8a/Vol.IX/4475. A written informed consent will be provided to the study participants. This protocol has been disseminated in the Bergen Centre for Ethics and Priority Setting International Symposium, Norway and the 11th Muhimbili University of Health and Allied Sciences Scientific Conference, Tanzania in 2023. The findings will be published in peer-reviewed journals for use by the academic community, researchers and health practitioners.